Free Trial

Laboratory Co. of America (LH) Competitors

$215.87
-0.63 (-0.29%)
(As of 07/17/2024 ET)

LH vs. DGX, DVA, CHE, RCM, CRVL, AMED, AMN, MD, CCRN, and NTRA

Should you be buying Laboratory Co. of America stock or one of its competitors? The main competitors of Laboratory Co. of America include Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), R1 RCM (RCM), CorVel (CRVL), Amedisys (AMED), AMN Healthcare Services (AMN), Pediatrix Medical Group (MD), Cross Country Healthcare (CCRN), and Natera (NTRA).

Laboratory Co. of America vs.

Quest Diagnostics (NYSE:DGX) and Laboratory Co. of America (NYSE:LH) are both large-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, community ranking, dividends, media sentiment and analyst recommendations.

Quest Diagnostics has a beta of 0.89, indicating that its share price is 11% less volatile than the S&P 500. Comparatively, Laboratory Co. of America has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500.

Quest Diagnostics has higher earnings, but lower revenue than Laboratory Co. of America. Quest Diagnostics is trading at a lower price-to-earnings ratio than Laboratory Co. of America, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Quest Diagnostics$9.25B1.78$854M$7.4319.99
Laboratory Co. of America$12.16B1.50$418M$4.9743.43

Laboratory Co. of America received 78 more outperform votes than Quest Diagnostics when rated by MarketBeat users. Likewise, 64.08% of users gave Laboratory Co. of America an outperform vote while only 49.44% of users gave Quest Diagnostics an outperform vote.

CompanyUnderperformOutperform
Quest DiagnosticsOutperform Votes
525
49.44%
Underperform Votes
537
50.56%
Laboratory Co. of AmericaOutperform Votes
603
64.08%
Underperform Votes
338
35.92%

88.1% of Quest Diagnostics shares are held by institutional investors. Comparatively, 95.9% of Laboratory Co. of America shares are held by institutional investors. 0.8% of Quest Diagnostics shares are held by insiders. Comparatively, 0.9% of Laboratory Co. of America shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Quest Diagnostics presently has a consensus target price of $149.31, indicating a potential upside of 0.51%. Laboratory Co. of America has a consensus target price of $241.29, indicating a potential upside of 11.77%. Given Quest Diagnostics' stronger consensus rating and higher possible upside, analysts clearly believe Laboratory Co. of America is more favorable than Quest Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Quest Diagnostics
0 Sell rating(s)
9 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.31
Laboratory Co. of America
0 Sell rating(s)
3 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.79

Quest Diagnostics pays an annual dividend of $3.00 per share and has a dividend yield of 2.0%. Laboratory Co. of America pays an annual dividend of $2.88 per share and has a dividend yield of 1.3%. Quest Diagnostics pays out 40.4% of its earnings in the form of a dividend. Laboratory Co. of America pays out 57.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Quest Diagnostics has raised its dividend for 13 consecutive years. Quest Diagnostics is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Quest Diagnostics has a net margin of 9.11% compared to Quest Diagnostics' net margin of 3.52%. Laboratory Co. of America's return on equity of 15.52% beat Quest Diagnostics' return on equity.

Company Net Margins Return on Equity Return on Assets
Quest Diagnostics9.11% 15.52% 7.23%
Laboratory Co. of America 3.52%14.68%7.03%

In the previous week, Quest Diagnostics had 11 more articles in the media than Laboratory Co. of America. MarketBeat recorded 24 mentions for Quest Diagnostics and 13 mentions for Laboratory Co. of America. Quest Diagnostics' average media sentiment score of 0.79 beat Laboratory Co. of America's score of 0.75 indicating that Laboratory Co. of America is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Quest Diagnostics
9 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Laboratory Co. of America
6 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Laboratory Co. of America beats Quest Diagnostics on 11 of the 21 factors compared between the two stocks.

Get Laboratory Co. of America News Delivered to You Automatically

Sign up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LH vs. The Competition

MetricLaboratory Co. of AmericaMedical laboratories IndustryMedical SectorNYSE Exchange
Market Cap$18.20B$2.30B$5.32B$18.56B
Dividend Yield1.39%2.00%2.76%3.50%
P/E Ratio43.4319.51137.9325.61
Price / Sales1.50140.842,136.2716.62
Price / Cash10.20341.9135.5420.26
Price / Book2.334.384.995.14
Net Income$418M-$128.23M$110.93M$974.76M
7 Day Performance4.68%6.95%2.73%2.97%
1 Month Performance4.54%10.40%9.40%6.48%
1 Year Performance1.48%-7.14%5.88%9.05%

Laboratory Co. of America Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DGX
Quest Diagnostics
4.9018 of 5 stars
4.90 / 5 stars
$144.11
+0.4%
$148.69
+3.2%
+6.2%$16.01B$9.25B19.4048,000Upcoming Earnings
Analyst Forecast
Analyst Revision
DVA
DaVita
3.7785 of 5 stars
3.78 / 5 stars
$141.55
+0.9%
$144.67
+2.2%
+33.6%$12.41B$12.14B16.0970,000Positive News
CHE
Chemed
4.9135 of 5 stars
4.91 / 5 stars
$537.87
+0.4%
$673.50
+25.2%
+0.0%$8.14B$2.26B28.9515,087Upcoming Earnings
Short Interest ↑
News Coverage
Positive News
RCM
R1 RCM
3.8497 of 5 stars
3.85 / 5 stars
$12.61
+1.0%
$16.00
+26.9%
-29.5%$5.31B$2.25B-157.6330,000
CRVL
CorVel
0.4684 of 5 stars
0.47 / 5 stars
$266.71
+1.7%
N/A+36.8%$4.58B$795.31M60.624,870Insider Selling
News Coverage
AMED
Amedisys
2.9034 of 5 stars
2.90 / 5 stars
$98.09
-0.2%
$100.67
+2.6%
+7.4%$3.21B$2.24B-153.2619,000Upcoming Earnings
Positive News
AMN
AMN Healthcare Services
4.9412 of 5 stars
4.94 / 5 stars
$49.82
+1.0%
$75.57
+51.7%
-48.0%$1.89B$3.79B13.393,585Short Interest ↑
Analyst Revision
News Coverage
MD
Pediatrix Medical Group
1.7797 of 5 stars
1.78 / 5 stars
$7.40
+2.6%
$9.10
+23.0%
-43.3%$622.69M$1.99B-8.715,170Analyst Forecast
News Coverage
CCRN
Cross Country Healthcare
4.5139 of 5 stars
4.51 / 5 stars
$13.79
+1.5%
$20.83
+51.1%
-44.0%$479.53M$2.02B10.6110,831Positive News
NTRA
Natera
1.3465 of 5 stars
1.35 / 5 stars
$111.60
+0.7%
$101.19
-9.3%
+124.1%$13.70B$1.08B-35.773,293Insider Selling
Positive News

Related Companies and Tools

This page (NYSE:LH) was last updated on 7/18/2024 by MarketBeat.com Staff

From Our Partners